Skip to main content
Sarcoma logoLink to Sarcoma
. 2001 Jun;5(2):89–94. doi: 10.1155/S1357714X01000172

Diagnosing Musculoskeletal Tumours

Robert J Grimer 1,2,, Simon R Carter 1, David Spooner 1, Rodney S Sneath 1
PMCID: PMC2395457  PMID: 18521309

Abstract

In 1993 we became aware of a worrying increase in apparent errors in the histopathological diagnosis of musculoskeletal tumours in our Unit. As a result all cases seen over the past 8 years were reviewed by an independent panel. Of the 1996 cases reviewed there was an error in 87. In 54 cases (2.7%) this had led to some significant change in the active management of the patient. The main areas where errors arose were in those very cases where clinical and radiological features were not helpful in confirming or refuting the diagnosis. The incidence of errors rose with the passage of time, possibly related to a deterioration in the pathologist’s health. The error rate in diagnosing bone tumours in previously published series ranges from 9 to 40%. To ensure as accurate a rate of diagnosis as possible multidisciplinary working and regular audit are essential.

Full Text

The Full Text of this article is available as a PDF (91.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Furness P. N., Lauder I. A questionnaire-based survey of errors in diagnostic histopathology throughout the United Kingdom. J Clin Pathol. 1997 Jun;50(6):457–460. doi: 10.1136/jcp.50.6.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Grimer R. J., Sneath R. S. Diagnosing malignant bone tumours. J Bone Joint Surg Br. 1990 Sep;72(5):754–756. doi: 10.1302/0301-620X.72B5.2211748. [DOI] [PubMed] [Google Scholar]
  3. Harris M., Hartley A. L., Blair V., Birch J. M., Banerjee S. S., Freemont A. J., McClure J., McWilliam L. J. Sarcomas in north west England: I. Histopathological peer review. Br J Cancer. 1991 Aug;64(2):315–320. doi: 10.1038/bjc.1991.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kurt A. M., Unni K. K., McLeod R. A., Pritchard D. J. Low-grade intraosseous osteosarcoma. Cancer. 1990 Mar 15;65(6):1418–1428. doi: 10.1002/1097-0142(19900315)65:6<1418::aid-cncr2820650629>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  5. Lind A. C., Bewtra C., Healy J. C., Sims K. L. Prospective peer review in surgical pathology. Am J Clin Pathol. 1995 Nov;104(5):560–566. doi: 10.1093/ajcp/104.5.560. [DOI] [PubMed] [Google Scholar]
  6. Mankin H. J., Lange T. A., Spanier S. S. The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am. 1982 Oct;64(8):1121–1127. [PubMed] [Google Scholar]
  7. Mankin H. J., Mankin C. J., Simon M. A. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am. 1996 May;78(5):656–663. doi: 10.2106/00004623-199605000-00004. [DOI] [PubMed] [Google Scholar]
  8. Presant C. A., Russell W. O., Alexander R. W., Fu Y. S. Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience. J Clin Oncol. 1986 Nov;4(11):1658–1661. doi: 10.1200/JCO.1986.4.11.1658. [DOI] [PubMed] [Google Scholar]
  9. Remagen W. Bedeutung von Referenz-Registern in der Knochentumor-Diagnostik. Erfahrungen im Schweizer Knochentumor-Register. Z Orthop Ihre Grenzgeb. 1992 Jul-Aug;130(4):267–268. doi: 10.1055/s-2008-1039615. [DOI] [PubMed] [Google Scholar]
  10. Souhami R. L., Craft A. W., Van der Eijken J. W., Nooij M., Spooner D., Bramwell V. H., Wierzbicki R., Malcolm A. J., Kirkpatrick A., Uscinska B. M. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet. 1997 Sep 27;350(9082):911–917. doi: 10.1016/S0140-6736(97)02307-6. [DOI] [PubMed] [Google Scholar]

Articles from Sarcoma are provided here courtesy of Wiley

RESOURCES